RenovoRx Research Development from 2010 to 2026
| RNXT Stock | USD 0.93 0.04 4.12% |
Research Development | First Reported 2020-03-31 | Previous Quarter 1.4 M | Current Value 1.7 M | Quarterly Volatility 459.7 K |
Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 463.7 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 567, Dividend Yield of 0.0 or PTB Ratio of 14.83. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.
RenovoRx | Research Development | Build AI portfolio with RenovoRx Stock |
The evolution of Research Development for RenovoRx provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how RenovoRx compares to historical norms and industry peers.
Latest RenovoRx's Research Development Growth Pattern
Below is the plot of the Research Development of RenovoRx over the last few years. It is RenovoRx's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in RenovoRx's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
RenovoRx Research Development Regression Statistics
| Arithmetic Mean | 3,693,696 | |
| Geometric Mean | 3,517,367 | |
| Coefficient Of Variation | 35.67 | |
| Mean Deviation | 1,050,512 | |
| Median | 2,997,000 | |
| Standard Deviation | 1,317,383 | |
| Sample Variance | 1.7T | |
| Range | 4.5M | |
| R-Value | 0.70 | |
| Mean Square Error | 932.3B | |
| R-Squared | 0.50 | |
| Significance | 0 | |
| Slope | 183,806 | |
| Total Sum of Squares | 27.8T |
RenovoRx Research Development History
About RenovoRx Financial Statements
RenovoRx shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although RenovoRx investors may analyze each financial statement separately, they are all interrelated. The changes in RenovoRx's assets and liabilities, for example, are also reflected in the revenues and expenses on on RenovoRx's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 6.9 M | 4.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.